文献速递新发突发、热带与寄生虫病细菌感染、耐药与抗菌药物

磺胺多辛-乙胺嘧啶耐药对乌干达北部孕妇出生体重及寄生虫持续性的影响

Effect of sulphadoxine-pyrimethamine resistance on birthweight and parasite persistence among women receiving intermittent preventive treatment for malaria in pregnancy in Northern Uganda: a directed acyclic graph-guided analysis.
PubMed 文献 · Clin Microbiol Infect · 2026-08-13

2022年7月至2023年10月在乌干达北部三家卫生机构开展前瞻性队列研究,纳入462名有疟原虫血症的孕妇。结果显示耐药单倍型与出生体重(-77 g,p=0.330)及寄生虫持续性(aOR 3.81,p=0.166)均无显著关联;初产妇婴儿出生体重较经产妇低238 g(95%CI:-38至-96 g,p=0.001);感染后每增加一剂SP-IPTp与随访时寄生虫持续性风险升高相关(aOR 1.90,95%CI:1.28-2.82,p=0.002)。

要点

  • 耐药单倍型与出生体重及寄生虫持续性无显著关联
  • 初产妇婴儿出生体重较经产妇低238 g,尽管SP-IPTp覆盖率接近普遍
  • 感染后追加SP-IPTp剂量与寄生虫持续性风险升高相关(aOR 1.90)

核心结论

  • 耐药单倍型对出生体重和寄生虫持续性均无显著影响。
  • 初产妇婴儿出生体重显著低于经产妇,尽管SP-IPTp覆盖接近普遍且接受标准病例管理。
  • 检测到感染后每增加一剂SP-IPTp与随访时寄生虫持续性风险升高相关。

研究设计与样本

  • 2022年7月至2023年10月在乌干达北部三家卫生机构开展基于设施的前瞻性队列研究。
  • 纳入产前保健孕妇,仅462名有疟原虫血症者进入分析,278例(60.1%)感染成功基因分型。
  • 采用有向无环图指导多变量建模,并应用逆概率加权校正测序相关选择偏倚。

主要发现

  • 278例成功基因分型中82%为五重突变体,14%为六重突变体。
  • 耐药单倍型与出生体重无显著关联(-77 g,p=0.330)。
  • 耐药单倍型与寄生虫持续性无显著关联(aOR 3.81,p=0.166)。
  • 初产妇婴儿出生体重较经产妇低238 g(95%CI:-38至-96 g,p=0.001)。
  • 感染后每增加一剂SP-IPTp与随访时寄生虫持续性风险升高相关(aOR 1.90,95%CI:1.28-2.82,p=0.002)。

关键数值与推荐

  • SP-IPTp为推荐预防治疗,其疗效受恶性疟原虫dhfr(N51I、C59R、S108N、I164L)和dhps(A437G、K540E、A581G)基因突变驱动的耐药威胁。
  • 确诊感染采用标准抗疟治疗,与SP-IPTp不同。
  • 仅纳入有疟原虫血症的孕妇,结局为出生体重和寄生虫持续性。

临床怎么用

  • 在SP耐药高流行区,耐药单倍型本身未显著影响出生体重或寄生虫清除,提示SP-IPTp仍可维持部分获益。
  • 初产妇是出生体重不良的高危人群,尽管接受SP-IPTp,仍需加强监测和干预。
  • 感染后追加SP-IPTp剂量可能与寄生虫持续性风险升高相关,提示需评估给药时机策略。

局限性

  • 仅纳入了有疟原虫血症的孕妇,可能限制结果的普遍性。
  • 278例成功基因分型,测序相关选择偏倚虽经逆概率加权校正但仍可能存在。
  • 研究为观察性设计,不能完全排除残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In 2023, malaria infected 12 million pregnant women in Africa. Preventive treatment with sulphadoxine-pyrimethamine (SP-IPTp) is recommended, but its efficacy is threatened by parasite resistance, driven by mutations in the Plasmodium falciparum dhfr (N51I, C59R, S108N, I164L) and dhps (A437G, K540E, A581G) genes. We assessed the effect of resistant infections on birthweight and examined the effectiveness of SP-IPTp dose timing on parasite persistence. METHODS: Between July 2022 and October 2023, we conducted a facility-based prospective cohort study among pregnant women attending antenatal care (ANC) in three health facilities in Northern Uganda. Eligible participants were those with confirmed pregnancy, informed consent, and delivery planned at the study site. At each ANC visit, malaria screening by microscopy was performed, and blood samples from positive cases were analysed for dhfr/dhps resistance markers through PCR and Sanger sequencing. Confirmed infections were treated with standard antimalarial therapy, distinct from SP-IPTp. Only women with parasitaemia were included in the analysis, and outcomes were birthweight and parasite persistence. Multivariable modelling was guided by directed acyclic graphs, and inverse probability weighting was applied to correct for sequencing-related selection bias. RESULTS: Of 462 women with parasitaemia, 278 (60.1%) infections were successfully genotyped, of which 82% were quintuple and 14% were sextuple mutants. Adjusted analysis found no significant association between resistance haplotypes and birthweight (-77 g, p = 0.330) nor parasite persistence (adjusted odds ratio: 3.81, p = 0.166). Infants of primigravidae weighed 238 g less (95% CI: -38 to -96 g, p = 0.001) than those of multigravidae, despite near-universal SP-IPTp coverage and standard case management. In contrast, each additional SP-IPTp dose administered after a detected infection was associated with higher odds of persistent parasitaemia at follow-up ANC visits (adjusted odds ratio: 1.90, 95% CI: 1.28-2.82; p = 0.002). CONCLUSIONS: Resistant haplotypes affected neither birthweight nor persistence. However, birthweight was significantly inferior among primigravidae despite SP-IPTp, and postinfection dosing was associated with increased risk of persistence.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Segala FV, Ictho J, L'episcopia M, et al. Effect of sulphadoxine-pyrimethamine resistance on birthweight and parasite persistence among women receiving intermittent preventive treatment for malaria in pregnancy in Northern Uganda: a directed acyclic graph-guided analysis. Clin Microbiol Infect. 2026. PMID: 42595091. doi:10.1016/j.cmi.2026.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。